Ann: Details for Immutep Webcast & ESMO Virtual Plenary Session, page-13

Accelerating Research to Practice

The ESMO Virtual Plenaries are monthly presentations of the latest, original scientific data from:

• Randomized phase III trials in oncology
• Phase II trials which demonstrate remarkable therapeutic benefit, scientific insight or progress in an area of unmet need
• Phase I/II studies and translational research that provide impactful data on mechanisms of action, biomarkers, and novel precision oncology therapeutics
• Real-world data series of high quality evidence on effectiveness, biomarker discovery/validation, treatment strategies, safety, resource allocation

Abstracts will be accepted for presentation based on the following criteria:

• Full abstract submission of original data to be presented by independent investigators, in accordance with the ESMO Congress abstract regulations.
• Submitted abstracts to be reviewed by the ESMO Congress Scientific Chair(s), the appropriate Scientific Track Chairs and a panel of independent experts
• Accepted abstracts will be presented and discussed during live 60-minute sessions.
• Presented abstracts will be published in Annals of Oncology and eligible for encore presentation at the following ESMO Congress.

It seems there is a bit involved to get a gig at one of these sessions, let's hope it's enough to get us moving again...